Correcting And Replacing Senju Pharmaceutical And Novaliq Enter Into License Agreement For Nov03 Perfluorohexyl Octane Ophthalmic Solution For The Treatment Of Dry Eye Disease In Japan
CORRECTING and REPLACING Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03 (Perfluorohexyl octane Ophthalmic Solution) For the Treatment of Dry Eye Disease in Japan
SENJU PHARMACEUTICAL AND NOVALIQ ENTER INTO LICENSE AGREEMENT FOR NOV03 (PERFLUOROHEXYLOCTANE OPHTHALMIC SOLUTION) FOR THE TREATMENT OF DRY EYE DISEASE IN JAPAN
Senju Pharmaceutical Co., Ltd., a researched-based Japanese pharmaceutical company focusing the field of ophthalmology, and Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique EyeSol
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!